Fundraising Fox
/Companies
Sign in

Swift Sync

Miami Shores, US · Founded 2021 · 3 known investors

Find your way into Swift Sync

Swift Sync develops a patented temporary A-V sequential pacing catheter that self-positions in the right-side heart chambers to maintain endocardium contact for synchronous dual-chamber pacing, potentially without fluoroscopic guidance. It is intended for use in operating rooms, cath labs, and critical care settings for procedures such as open heart surgery, TAVR, ablations, and conditions like bradycardia and heart block.

Advanced ManufacturingHardwareHealthtechMedical Devices

Founders & leadership

CM
Christian Marin y KallChief Operating Officer
RT
Richard TorenCEO
ED
Eduardo de MarchenaChief Medical Officer

Investors · 3

New World AngelsreportedBoca Raton

How we know: funding news · refreshmiami.com · Not right? Tell us

Also in the syndicate · 1

OceanAzul

Funding

SEC filings, press & company announcements

$4.4M disclosed across 2 of 3 rounds · 2021–2024

▶$1.5MraisedFeb 2024 · 15 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert WilliamsonDirector
  • Kenneth RubensteinDirector
  • Richard TorenExecutive Officer, Director
  • Eduardo de MarchenaDirector
  • Christopher CampbellDirector
  • William PruittDirector
  • William O'NeillDirector
  • Christian Marin y KallExecutive Officer
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedJun 2021 · 16 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Christian Marin y KallExecutive Officer
  • Richard TorenExecutive Officer
  • Eduardo de MarchenaExecutive Officer
Offering amount
$3.5M
Amount sold
$2.9M
Proceeds to insiders
$250K
First sale
May 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Swift Sync do?
Swift Sync develops a patented temporary A-V sequential pacing catheter that self-positions in the right-side heart chambers to maintain endocardium contact for synchronous dual-chamber pacing, potentially without fluoroscopic guidance. It is intended for use in operating rooms, cath labs, and critical care settings for procedures such as open heart surgery, TAVR, ablations, and conditions like bradycardia and heart block.
Who are Swift Sync's investors?
Swift Sync's investors include Ocean Azul Partners, New World Angels.
How much funding has Swift Sync raised?
Swift Sync has disclosed $4.4M raised across 2 of its 3 known rounds.
Where is Swift Sync headquartered?
Swift Sync is headquartered in Miami Shores, US.